4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like Array BioPharma And Bristol-Myers Squibb Announce Strategic Collaboration May 29, 2017 Zynerba Release: Company Announces Proposed Public Offering Of Common Stock January 18, 2017 INVO Bioscience Reports First Quarter 2017 Financial Results May 15, 2017
